[Skip to Content]

Statements

Macular Society’s call for more funding of research into macular degeneration

Jun 28
2016

Statement from the Macular Society Charity’s landmark report exposing lack of investment in age-related macular degeneration (AMD) is supported by more than 60 of the UK’s foremost sight researchers, ophthalmologists and institutions – Situation described as ‘urgent’ It is a disease with devastating and far-reaching consequences for both patients and their families, and the number of

  • 28 June 2016

RCOphth welcomes agreement on the new junior doctor contract

Jun 01
2016

The Royal College of Ophthalmologists welcomes the agreement on the new junior contract and is hopeful that the new terms and conditions will be met positively by the majority of junior doctors at referendum. The RCOphth noted that features of the new contract would impact ‘disproportionately on women’ and is pleased to see that this

  • 1 June 2016

Academy of Medical Royal Colleges statement on Junior Doctors contract

Mar 29
2016

The Academy of Medical Royal Colleges releases statement on the new contract for Junior Doctors, calling on both sides to ‘step back from the brink’. This is a time of unprecedented crisis for the NHS. With this in mind and in the spirit of placing patient welfare first and foremost we are writing in response to

  • 29 March 2016

Competency Framework

Jan 21
2016

Carrie MacEwen, on behalf of the RCOphth, has been working with the College of Optometrists (CoO), Royal College of Nursing (RCN), British and Irish Orthoptic Society (BIOS) and Association of Health Professions in Ophthalmology (AHPO) on developing a Competency Framework for expanded ophthalmic roles for Ophthalmic Nurses, Optometrists, Orthoptists and Ophthalmic Clinical Scientists. Despite hospital

  • 21 January 2016

Response to NICE guidance on Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears

Dec 16
2015

Ciclosporin (1mg/ml, Ikervis®) is a sterile, positively charged, oil-in water, unpreserved ophthalmic emulsion for the treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes. It is  administered as a once daily eye drop at bed time. The Royal College of Ophthalmologists welcomes the decision

  • 16 December 2015